Effects of soy protein and isoflavones on insulin resistance and adiponectin in male monkeys

Metabolism: Clinical and Experimental

Volumn 57, Issue SUPPL. 1, 2008, Pages

  Wagner, Janice D ^a   Zhang, Li ^a   Shadoan, Melanie K ^b   Kavanagh, Kylie ^a   Chen, Haiying ^a   Tresnasari, Kristianti ^c   Kaplan, Jay R ^a   Adams, Michael R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b LEXICON PHARMACEUTICALS INC   (United States)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALCOHOL; CASEIN; INSULIN RECEPTOR; ISOFLAVONE DERIVATIVE; LACTALBUMIN; LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET; DOSE RESPONSE; FOOD INTAKE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; INTRAVENOUS GLUCOSE TOLERANCE TEST; LATIN SQUARE DESIGN; LIPOPROTEIN BLOOD LEVEL; MALE; MONKEY; MUSCLE BIOPSY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SKELETAL MUSCLE; TREATMENT DURATION;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DRUG EVALUATION, PRECLINICAL; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; ISOFLAVONES; MACACA FASCICULARIS; MALE; METABOLIC SYNDROME X; MUSCLE, SKELETAL; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; SOYBEAN PROTEINS;

EID: 44949161255     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.04.001     Document Type: Article

References (44)

1. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
2. Park Y.W., Zhu S., Palaniappan L., et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163 (2003) 427-436
3. DeFronzo R.A. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Reviews 5 (1997) 177-269
4. Shoelson S.E., Lee J., and Goldfine A.B. Inflammation and insulin resistance. J Clin Invest 116 (2006) 1793-1801
5. Kadowaki T., Yamauchi T., Kubota N., et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116 (2006) 1784-1792
6. Tan K.C.B., Xu A., Chow W.S., et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89 (2004) 765-769
7. Lihn A.S., Pedersen S.B., and Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obesity Rev 6 (2005) 13-21
8. Dang Z.C., Audinot V., Papapoulos S.E., et al. Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 278 (2003) 962-967
9. Dang Z.C., and Löwik C.W.G.M. The balance between concurrent activation of ERs and PPARs determine daidzein-induced osteogenesis and adipogenesis. J Bone Min Res 19 (2004) 853-861
10. Mezei O., Banz W.J., Steger R.W., et al. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 133 (2003) 1238-1243
11. Wagner J.D., Anthony M.S., and Cline J.M. Soy phytoestrogens: research on benefits and risks. Clin Obstet Gynecol 44 (2001) 843-852
12. Friedenwald J., and Ruhrah J. The use of the soy bean as a food in diabetes. American Journal of Medical Science 140 (1910) 793-803
13. Jayagopal V., Albertazzi P., Kilpatrick E.S., et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25 (2002) 1709-1714
14. Goodman-Gruen D., and Kritz-Silverstein D. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131 (2001) 1202-1206
15. Wagner J.D., Cefalu W.T., Anthony M.S., et al. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism 46 (1997) 698-705
16. Hermansen K., Sondergaard M., Hoie L., et al. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24 (2001) 228-233
17. Wagner J.D., Zhang L., Greaves K.A., et al. Soy protein reduces the arterial low-density lipoprotein (LDL) concentration and delivery of LDL cholesterol to the arteries of diabetic and nondiabetic male cynomolgus monkeys. Metab Clin Exp 49 (2000) 1188-1196
18. Akiyama T., Ishida J., Nakagawa S., et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262 (1987) 5592-5595
19. Adams M.R., Golden D.L., Williams J.K., et al. Soy protein containing isoflavones reduces the size of atherosclerotic plaques without affecting coronary artery reactivity in adult male monkeys. J Nutr 135 (2005) 2852-2856
20. Shadoan M.K., Zhang L., Kavanagh K., et al. Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue. Metabolism. 56 (2007) 830-837
21. Wagner J.D., Thomas M.J., Williams J.K., et al. Insulin sensitivity and cardiovascular risk factors in ovariectomized monkeys with estradiol alone or combined with nomegestrol acetate. J Clin Endocrinol Metab 83 (1998) 896-901
22. Wagner J.D., Kavanagh K., Ward G., and Kaplan J. Old world primate models of type 2 diabetes mellitus. ILAR J 47 (2006) 259-271
23. Shadoan M.K., Zhang L., and Wagner J.D. Effects of hormone replacement therapy on insulin signaling proteins in skeletal muscle of cynomolgus monkeys. Steroids 69 (2004) 313-318
24. Berg A.H., Lin Y., Lisanti M.P., et al. Adipocyte differentiation induces dynamic changes in NF-kB expression and activity. Am J Physiol Endcrinol Metab 287 (2004) E1178-E1188
25. Costrini N.V., and Kalkhoff R.K. Relative effects of pregnancy, estradiol, and progesterone on plasma insulin and pancreatic islet insulin secretion. J Clin Invest 50 (1971) 992-999
26. Sorenson R.L., Brelje T.C., and Roth C. Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology 134 (1994) 1975-1978
27. Jonas J.C., Plant T.D., Gilon P., et al. Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets. Br J Pharmacol 114 (1995) 872-880
28. Liu D., Zhen W., Yang Z., et al. Genistein acutely stimulates insulin secretion in pancreatic b-cells through cAMP-dependent protein kinase pathway. Daibetes 55 (2006) 1043-1050
29. Hill T.D., Dean N.M., Mordan L.J., et al. PDGF-induced activation of phospholipase C is not required for induction of DNA synthesis. Science 248 (1990) 1660-1663
30. Abler A., Smith J.A., Randazzo P.A., et al. Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase. J Biol Chem 267 (1992) 3946-3951
31. Mackowiak P., Nogowski L., and Nowak K.W. Effect of isoflavone genistein on insulin receptors in perfused liver of ovariectomized rats. J Recept Signal Transduct Res 19 (1999) 283-292
32. Smith R.M., Tiesinga J.J., Shah N., et al. Genistein inhibits insulin-stimulated glucose transport and decreases immunocytochemical labeling of GLUT4 carboxyl-terminus without affecting translocation of GLUT4 in isolated rat adipocytes: additional evidence of GLUT4 activation by insulin. Arch Biochem Biophys 300 (1993) 238-246
33. Li Y., and Sarkar F.H. Inhibition of nuclear factor kB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res 8 (2002) 2369-2377
34. Stauffer B.L., Konhilas J.P., Luczak E.D., et al. Soy diet worsens heart disease in mice. J Clin Invest 116 (2006) 209-216
35. Harmon A.W., and Harp J.B. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am J Physiol Cell Physiol 280 (2001) C807-C813
36. Harmon A.W., Patel Y.M., and Harp J.B. Genistein inhibits CCAAT/enhancer-binding protein beta (C/EBPbeta) activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression. Biochem J 367 Pt 1 (2002) 203-208
37. Tcherepanova I., Puigserver P., Norris J.D., et al. Modulation of estrogen receptor-alpha transcriptional activity by the coactivator PGC-1. J Biol Chem 275 (2000) 16302-16308
38. Morifuji M., Sanbongi C., and Sugiura K. Dietary soya protein intake and exercise training have an additive effect on skeletal muscle fatty acid oxidation enzyme activities and mRNA levels in rats. Br J Nutrition 96 (2006) 469-475
39. Nagasawa A., Fukui K., Funahashi T., et al. Effects of soy protein diet on the expression of adipose genes and plasma adiponectin. Horm Metab Res 34 (2002) 635-639
40. Nagasawa A., Fukui K., Kojima M., et al. Divergent effects of soy protein diet on the expression of adipocytokines. Biochem Biophys Res Commun 311 (2003) 909-914
41. Christie D.R., Cooper B.C., Lyon D., et al. Effect of soy phytoestrogens on systemic markers of inflammation and adiposity in postmenopausal women. Fertil Steril 86 Suppl 2 (2006) S90
42. Stroud F.C., Appt S.E., Wilson M.E., et al. Concentrations of isoflavones in macaques consuming standard laboratory monkey diet. J Am Assoc Lab Anim Sci 45 (2006) 20-23
43. Moriyama T., Kishimoto K., Nagai K., et al. Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption. Biosci Biotech Biochem 68 (2004) 352-359
44. Lovati M., Manzoni C., Gianazza E., et al. Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J Nutr 130 (2000) 2543-2549